Multidrug resistance (MDR) in acute myeloid leukemia (AML) with core-binding factor (CBF) abnormalities.

被引：0
|
作者：
Baer, MR [1 ]
O'Loughlin, KL [1 ]
Minderman, H [1 ]
Sait, SN [1 ]
Flood, JJ [1 ]
Sorci, JJ [1 ]
Stewart, CC [1 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
273
引用
收藏
页码：64A / 64A
页数：1
相关论文
共 50 条
  • [1] Molecular Characterization of Relapsed Core-Binding Factor (CBF) Acute Myeloid Leukemia (AML)
    Agrawal, Mridul
    Corbacioglu, Andrea
    Jahn, Nikolaus
    Bullinger, Lars
    Teleanu, Maria-Veronica
    Gaidzik, Verena I.
    Weber, Daniela
    Goehring, Gudrun
    Luebbert, Michael
    Fiedler, Walter
    Brossart, Peter
    Kindler, Thomas
    Radsak, Markus
    Ringhoffer, Mark
    Goetze, Katharina S.
    Greil, Richard
    Thol, Felicitas
    Heuser, Michael
    Ganser, Arnold
    Schlenk, Richard F.
    Doehner, Hartmut
    Paschka, Peter
    Doehner, Konstanze
    BLOOD, 2015, 126 (23)
  • [2] Mutational Landscape of Relapsed Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)
    Dolnik, Anna
    Jahn, Nikolaus
    Strang, Eric
    Cocciardi, Sibylle
    Rucker, Frank G.
    Panina, Ekaterina
    Blatte, Tamara J.
    Herzig, Julia Katharina
    Corbacioglu, Andrea
    Weber, Daniela
    Schrade, Anika
    Gaidzik, Verena I.
    Skambraks, Sabrina
    Gotze, Katharina S.
    Luebbert, Michael
    Fiedler, Walter
    Schroeder, Thomas
    Hahn, Corinna
    Thol, Felicitas
    Heuser, Michael
    Ganser, Arnold
    Paschka, Peter
    Dohner, Hartmut
    Dohner, Konstanze
    Bullinger, Lars
    BLOOD, 2020, 136
  • [3] Additional chromosomal abnormalities in core-binding factor acute myeloid leukemia
    Hsiao, H. H.
    Liu, Y. C.
    Wang, H. C.
    Tsai, Y. F.
    Wu, C. H.
    Cho, S. F.
    Hsu, J. F.
    Huang, C. T.
    Hsiao, S. Y.
    Lee, C. P.
    Chang, C. S.
    Lin, S. F.
    Liu, T. C.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04) : 17028 - 17033
  • [4] Core-Binding Factor Acute Myeloid Leukemia
    Sangle, Nikhil A.
    Perkins, Sherrie L.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2011, 135 (11) : 1504 - 1509
  • [5] THREE CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIAS (CBF-AML) IN A SINGLE PATIENT
    Markova, J.
    Polak, J.
    Haskovec, C.
    Maaloufova, J.
    Markova, M.
    Soukup, P.
    Salek, C.
    Vrana, M.
    Dobrovolna, M.
    Vitek, A.
    Cetkovsky, P.
    Schwarz, J.
    HAEMATOLOGICA, 2013, 98 : 522 - 522
  • [6] CORE-BINDING FACTOR IN CHILDHOOD ACUTE MYELOID LEUKEMIA
    Kassar, O.
    Charfi, M.
    Kallel, F.
    Ghorbel, M.
    Mdhaffar, M.
    Abdejellil, N.
    Bellaaj, H.
    Hdijji, S.
    ben Othmen, T.
    Elloumi, M.
    HAEMATOLOGICA, 2015, 100 : 375 - 375
  • [7] Granulocytic sarcoma of Core-binding Factor (CBF) acute myeloid leukemia mimicking pancreatic cancer
    Schaefer, Henning Sebastian
    Becker, Heiko
    Schmitt-Graeff, Annette
    Luebbert, Michael
    LEUKEMIA RESEARCH, 2008, 32 (09) : 1472 - 1475
  • [8] GENOMIC LANDSCAPE OF CORE-BINDING FACTOR ACUTE MYELOID LEUKEMIA
    Duployez, N.
    Marceau-Renaut, A.
    Boissel, N.
    Petit, A.
    Bucci, M.
    Geffroy, S.
    Ragu, C.
    Celli-Lebras, K.
    Lacombe, C.
    Ifrah, N.
    Dombret, H.
    Leverger, G.
    Jourdan, E.
    Lapillonne, H.
    Preudhomme, C.
    HAEMATOLOGICA, 2015, 100 : 209 - 209
  • [9] Kit Mutations at Exon-17 Correlate with Adverse Survival in Children with Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)
    Srinivasan, S.
    Dhamne, C.
    Moulik, N. Roy
    Shetty, D.
    Tembhare, P.
    Patkar, N.
    Pg, S.
    Narula, G.
    Banavali, S. D.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S91 - S91
  • [10] Prognostic value of the expression of multidrug resistance (MDR) in acute myeloid leukemia (AML).
    Arbelbide, J
    Rivello, HG
    Fantl, G
    Iastrebner, M
    Vinuales, S
    Penchasky, D
    Nucifora, E
    Morandi, A
    BLOOD, 1997, 90 (10) : 3664 - 3664
12345